INSIGHTS ON QUALITY CONTROL

• Leachables Method Development, Validation And Relevant ICH References

  It is crucial to develop and validate analytical methods capable of detecting a wide range of potential organic and inorganic leachables specific to the drug and its packaging.

• Aseptic Expertise And Delivery Of Services

  A pharmaceutical services company sought expert intervention after a routine requalification of their aseptic simulation process revealed a contaminated unit, halting commercial production for two months.

• The Problem With Construction Quality

  Data center construction quality management is inadequate, with issues traced to human error. A stronger focus on quality control and assurance is needed for success.

• Development To Large-Scale cGMP Production

  For manufacturers working with a dry powder medium (DPM), early consultation with a supplier can increase the likelihood of success. Uncover a two-phase scale-up strategy for the production of DPM.

• Which X-Ray, Metal Detector, Or Checkweigher Is Right For Your Industry?

  5/18/2026

  Navigate the complexities of pharmaceutical safety with a guide to tailored inspection systems. Match the right technology to your specific product format for total compliance and quality.

• How Do You Navigate GxP Compliance?

  4/21/2026

  Heightened FDA scrutiny demands a shift from fragmented data to unified digital systems. Learn how to automate QA tasks, secure data integrity, and maintain a constant state of inspection readiness.

• Why Pharmaceutical Scientists Trust The Discovery Core Rheometer

  5/1/2026

  Drug formulations demand more than single‑point viscosity data. Explore how rheology reveals stability, flow, and structural behavior across suspensions, topicals, and injectables.

• 6 Trends Redefining Biologics Manufacturing In 2026

  5/14/2026

  Biologics manufacturing is evolving through smarter fill technologies, onshoring, advanced automation, and data driven processes that improve efficiency, reduce risk, and protect product value.

• Tackling Residual DNA Testing In Biotherapy Manufacturing

  7/16/2025

  Controlling residual host cell DNA is critical for the safety and efficacy of biotherapeutics. Learn about robust, highly sensitive analytical methods for effective DNA clearance and process control.